InsiderTrades

Form 4 for INM InMed Pharmaceuticals Inc.

Accepted 2026-07-16 21:58:22 ET · period of report 2026-07-14 · accession 0001213900-26-078891 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
MI 2026-07-16 21:58 2026-07-14+ INM Vivo Opportunity, LLC 10% P - Purchase $1.55 +20.5K 75.0K +38% +$31.8K

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Shares 2026-07-14 P A 4,882 $1.55 729,277 I By Vivo Opportunity Fund Holdings, L.P. — — (F1) Vivo Opportunity, LLC is the general partner of Vivo Opportunity Fund Holdings, L.P., the record holder of the securities. Vivo Opportunity, LLC disclaims beneficial ownership over such securities except to the extent of its pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.
2 Common Common Shares 2026-07-14 P A 493 $1.55 73,628 I By Vivo Opportunity Cayman Fund, L.P. — — (F2) Vivo Opportunity Cayman, LLC is the general partner of Vivo Opportunity Cayman Fund, L.P., the record holder of the securities. Vivo Opportunity Cayman, LLC disclaims beneficial ownership over such securities except to the extent of its pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.
3 Common Common Shares 2026-07-15 P A 13,761 $1.55 743,038 I By Vivo Opportunity Fund Holdings, L.P. — — (F1) Vivo Opportunity, LLC is the general partner of Vivo Opportunity Fund Holdings, L.P., the record holder of the securities. Vivo Opportunity, LLC disclaims beneficial ownership over such securities except to the extent of its pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.
4 Common Common Shares 2026-07-15 P A 1,389 $1.55 75,017 I By Vivo Opportunity Cayman Fund, L.P. — — (F2) Vivo Opportunity Cayman, LLC is the general partner of Vivo Opportunity Cayman Fund, L.P., the record holder of the securities. Vivo Opportunity Cayman, LLC disclaims beneficial ownership over such securities except to the extent of its pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.
5 Common Common Shares 2026-07-16 P A 19 $1.55 743,057 I By Vivo Opportunity Fund Holdings, L.P. — — (F1) Vivo Opportunity, LLC is the general partner of Vivo Opportunity Fund Holdings, L.P., the record holder of the securities. Vivo Opportunity, LLC disclaims beneficial ownership over such securities except to the extent of its pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.
6 Common Common Shares 2026-07-16 P A 2 $1.55 75,019 I By Vivo Opportunity Cayman Fund, L.P. — — (F2) Vivo Opportunity Cayman, LLC is the general partner of Vivo Opportunity Cayman Fund, L.P., the record holder of the securities. Vivo Opportunity Cayman, LLC disclaims beneficial ownership over such securities except to the extent of its pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.